VOX 📈 Voxel S.A. - Overview

Exchange: WAR • Country: Poland • Currency: PLN • Type: Common Stock • ISIN: PLVOXEL00014

VOX: Medical, Imaging, Diagnostic, Radiopharmaceuticals, Therapy, IT

Voxel S.A. operates a network of diagnostic imaging laboratories in Poland. The company operates in Diagnostics, Therapy, and IT segments. The company provides diagnostic imaging services, which include magnetic resonance imaging scans, computed tomography scans, and positron emission tomography; teleradiology services; and neuroradiosurgery services. It is also involved in nuclear medicine research. In addition, it operates neurological hospitals, laboratories for COVID-19 diagnostics, and information systems for hospitals; and offers clinical test services. Further, it produces and sells radiopharmaceuticals products. Voxel S.A. was incorporated in 2005 and is based in Kraków, Poland. Web URL: https://www.voxel.pl

Additional Sources for VOX Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

VOX Stock Overview

Market Cap in USD 319m
Sector Healthcare
Industry Diagnostics & Research
GiC Sub-Industry Biotechnology
IPO / Inception

VOX Stock Ratings

Growth 5y 93.1%
Fundamental 34.3%
Dividend 68.1%
Rel. Strength Industry 1222
Analysts -
Fair Price Momentum 154.56 PLN
Fair Price DCF 146.73 PLN

VOX Dividends

Dividend Yield 12m 2.24%
Yield on Cost 5y 10.70%
Annual Growth 5y 16.99%
Payout Consistency 93.9%

VOX Growth Ratios

Growth Correlation 3m 85.5%
Growth Correlation 12m 86%
Growth Correlation 5y 84.1%
CAGR 5y 35.31%
CAGR/Mean DD 5y 3.23
Sharpe Ratio 12m 1.49
Alpha 40.43
Beta 0.37
Volatility 36.86%
Current Volume 42.9k
Average Volume 20d 8.4k
What is the price of VOX stocks?
As of December 22, 2024, the stock is trading at PLN 117.50 with a total of 42,887 shares traded.
Over the past week, the price has changed by +0.40%, over one month by +7.36%, over three months by +14.81% and over the past year by +52.50%.
Is Voxel S.A. a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Voxel S.A. is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 34.33 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of VOX as of December 2024 is 154.56. This means that VOX is currently undervalued and has a potential upside of +31.54% (Margin of Safety).
Is VOX a buy, sell or hold?
Voxel S.A. has no consensus analysts rating.
What are the forecast for VOX stock price target?
According to ValueRays Forecast Model, VOX Voxel S.A. will be worth about 168.5 in December 2025. The stock is currently trading at 117.50. This means that the stock has a potential upside of +43.37%.
Issuer Forecast Upside
Wallstreet Target Price 94.3 -19.8%
Analysts Target Price - -
ValueRay Target Price 168.5 43.4%